drugset / Trial / NCT03039751
Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris
Phase 2
Completed
63 enrolled
Kuopio University Hospital
Euram Limited · collabFinVector Vision Therapies Oy · collabMedical University of Vienna · collabQueen Mary University of London · collabRigshospitalet, Denmark · collabServicio Madrileño de Salud, Madrid, Spain · collabUniversity College, London · collabŚląski Uniwersytet Medyczny w Katowicach · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to evaluate the safety and efficacy of catheter mediated endocardial adenovirus-mediated vascular endothelial growth factor-D (AdVEGF-D) regenerative gene transfer in patients with refractory angina to whom revascularisation cannot be performed.
Timeline
- Start
- 2019-10-19
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AdvVEGF-D | Unknown | 1e+11 unknown | Other |